S100A9 as a novel diagnostic and prognostic biomarker in human gastric cancer.

Conclusions: This study reveals that S100A9 may be a novel biomarker for the early diagnosis and prognosis of GC patients.
PMID: 32172630 [PubMed - as supplied by publisher]

Source: Scandinavian Journal of Gastroenterology - March 17, 2020 Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research